Genetic ablation of host MMP-2 in mice, and hence also in bone-lining osteoblasts, significantly delayed the growth of bone metastatic breast cancer, with reduced levels of TGFβ indicated as a contributing mechanism. This evidence concerns the gene MMP2 and breast cancer.